All Stories

  1. Epigenetic treatment of metastasis with hydralazine and valproic acid

    Article • OncoTargets and Therapy, December 2018, Dove Medical Press

    Enrique Pérez-Cárdenas, PhD LUCIA TAJA-CHAYEB, Dr Elizabeth Langley

  2. Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy

    Article • Expert Opinion on Investigational Drugs, May 2018, Taylor & Francis

    Enrique Pérez-Cárdenas, PhD LUCIA TAJA-CHAYEB